The increased awareness of obstructive sleep apnoea's (OSA) links to Alzheimer's disease and major psychiatric disorders has recently directed an intensified search for their potential shared mechanisms. We hypothesised that neuroinflammation and the microglial TLR2-system may act as a core process at the intersection of their pathophysiology. Moreover, we postulated that inflammatory-response might underlie development of key behavioural and neurostructural changes in OSA. Henceforth, we set out to investigate effects of 3 weeks' exposure to chronic intermittent hypoxia in mice with or without functional TRL2 (TLR2 +/+ , C57BL/6-Tyrc-Brd-Tg(Tlr2-luc/gfp)Kri/Gaj;TLR2 −/− ,C57BL/6-Tlr2tm1Kir). By utilising multimodal imaging in this established model of OSA, a discernible neuroinflammatory response was demonstrated for the first time. The septal nuclei and forebrain were shown as the initial key seed-sites of the inflammatory cascade that led to wider structural changes in the associated neurocircuitry. Finally, the modulatory role for the functional TLR2-system was suggested in aetiology of depressive, anxious and anorexiolytic symptoms in OSA. Obstructive sleep apnoea (OSA) is a major public health problem due to high prevalence and associated serious cardiovascular and metabolic complications 1,2. Its neuropsychiatric presentations and links to anxiety disorders, depression 2,3 and Alzheimer's disease (AD) are also increasingly recognised 4-7. The key mechanisms behind effects of OSA on the brain are unclear, and if established, they might aid the development of much needed novel therapeutic approaches. More recently, neuroinflammation and microglial Toll-like receptors 2 (TLR2) system 8 have been argued to act as a shared archetypal mechanism in the pathogenesis of AD, depression 9-11 and several other psychiatric disorders 12-14 with which OSA appears to share a complex bidirectional link 4,15. Neuroinflammation, however, has yet to be authoritatively demonstrated in OSA. Our group has long hypothesized that inflammatory response might arise during sleep in patients with OSA due to obstructive apnoeic events and associated intermittent hypoxia and arousals 16. Over the years we have